Related Experiment Video
Updated: Mar 27, 2026
A Net Mold-based Method of Scaffold-free Three-Dimensional Cardiac Tissue Creation
Published on: August 5, 2018
A novel 3-dimensional approach for cardiac regeneration
Insights
Researchers developed a collagen-alginate microsphere scaffold to promote new blood vessel growth after heart attacks. This innovative scaffold guides cell formation, offering a promising therapeutic approach for ischemic heart disease.
Area of Science:
- Biomaterials Science
- Regenerative Medicine
- Cardiovascular Research
Background:
- Ischemic heart diseases lead to cardiomyocyte death and impaired heart function.
- The heart lacks natural regenerative capabilities following ischemic events.
- Neovascularization is crucial for tissue repair and engineered constructs.
Purpose of the Study:
- To develop and characterize a collagen-alginate microsphere scaffold for promoting neovascularization.
- To evaluate the scaffold's ability to recruit and guide endothelial cells for vessel formation.
- To assess the therapeutic potential of the scaffold in cardiac repair after ischemia.
Main Methods:
- Fabrication and optimization of collagen-alginate microspheres for controlled drug release.
- In vitro studies using fibroblasts and human umbilical vein endothelial cells (HUVECs) to assess cellular compatibility and vessel formation.
- In vivo implantation of acellular scaffolds in rat hearts to evaluate host cell infiltration.
Main Results:
- Monodisperse 100 μm microspheres were achieved with controlled protein release over 3 days.
- Scaffolds demonstrated cellular compatibility with embedded fibroblasts.
- In vitro assays showed HUVECs forming vascular networks guided by the microsphere architecture.
- In vivo implantation confirmed host cell invasion into the acellular scaffolds.
Conclusions:
- The collagen-alginate microsphere scaffold is a viable and tunable approach for neovascularization.
- The scaffold provides structural cues that promote endothelial cell network formation.
- This technology holds potential for therapeutic applications in engineered tissues and post-ischemic cardiac repair.
Abstract:
Ischemic heart diseases, such as coronary artery disease and microvascular disease, are cardiovascular pathologies that cause reduced blood supply to the heart muscle. Acute and chronic ischemia cause cardiomyocytes to die, and these cells are not naturally replaced as part of the wound healing process in the heart. To promote neovascularization in the wound bed and in implanted engineered tissues, we have developed a collagen-alginate microspheres scaffold intended for local release of drugs and growth factors in order to recruit host endothelial cells to the area and provide them with geometrical cues to form new vessels. Optimization of alginate microspheres included modulation of nitrogen pressure, alginate and CaCl2 concentrations, nozzle size, and velocity of extrusion to achieve monodisperse populations of 100 μm diameter microspheres with protein release over 3 days. In vitro incorporation of fibroblasts in the bulk collagen demonstrated cellular compatibility with embedded alginate microspheres. An in vitro vessel formation assay, performed with human umbilical vein endothelial cells (HUVECs) immobilized in the collagen phase of the collagen-alginate microspheres scaffolds, showed that HUVECs formed networks following the 3-dimensional pattern of the microspheres even in the absence of growth factor. Implantation of acellular collagen-alginate microspheres scaffolds onto healthy rat hearts confirmed the invasion of host cells at one week. Together, these results suggest that the collagen-alginate microspheres scaffold is a viable, tunable therapeutic approach for directing neovascularization in engineered tissues and in the heart after ischemic events.
